Affiliation:
1. Dipartimento di Scienze Farmaceutiche, Università di Salerno, Fisciano, Italy
2. Dipartimento di Scienze Molecolari e Nanosistemi, Università Ca' Foscari di Venezia, Venezia, Italy
3. Dipartimento di Chimica, Università di Salerno, Fisciano, Italy
Abstract
Abstract
Objectives
In this work was to evaluate the cytotoxic activity of a series of monomeric group 3 and lanthanide (N,N,N)-heteroscorpionate-triflate complexes (M (OTf) 2 (cybpamd) (THF)) (Ln = Sc (2), Y (3), La (4), Nd (5), Sm (6), Dy (7), Yb (8); OTf = SO3CF3; cybpamd = N, N′-dicyclohexyl-2,2-bis-(3,5-dimethyl-pyrazol-1-yl)-acetamidinate) having octahedral geometry around the metal atoms on the human epithelial lung adenocarcinoma (A549), human melanoma (A375), human cervical epithelial adenocarcinoma, human embryonic kidney (HEK-293) and murine macrophages (J774.A1) cell lines.
Methods
All the tested compounds were incubated with cells for 72 h and their growth inhibition assessed by using MTT assay.
Key findings
On the cell line HEK-293 complexes 5 and 7 show a reasonable activities, while the murine macrophage cell line (J774.A1), only the scandium 2 complex is not very active. All complexes tested are poorly active on human health adenocarcinoma lung epithelial (A549) and human melanoma (A375).
Conclusions
The group 3 and lanthanide (N,N,N)-heteroscorpionate triflate-complexes (M(OTf)2(cybpamd)(THF)) on murine macrophage (J774.A1) cell line, except that of scandium, show a reasonable activity. On human epithelial cervix adenocarcinoma (HeLa) complexes 3, 5 and 6 are significantly more active than cis-platinum, as well as complex 5 is more active on human embryonic kidney (HEK-293) cell line. All the tested complexes are poorly active on human epithelial lung adenocarcinoma (A549) and human melanoma (A375).
The different behaviour of the complexes examined (2–8) let us hypothesize that the cytotoxic activity is related to the molecule as a whole and not only to the ligand or the metal ion separately.
Funder
Italian Ministry of University and Research
Publisher
Oxford University Press (OUP)
Subject
Pharmaceutical Science,Pharmacology
Reference38 articles.
1. The therapeutic application of lanthanides;Fricker;Chem Soc Rev,2006
2. Current status of platinum-based antitumor drugs;Wong;Chem Rev,1999
3. DNA binding and chemistry of dinuclear platinum complexes;Farrell;Comment Inorg Chem,1995
4. The status of platinum anticancer drugs in the clinic and in clinical trials;Wheate;Dalton Trans,2010
5. Cell responses to lanthanides and potential pharmacological actions of lanthanides;Wang;Met Ions Biol Syst,2003
Cited by
6 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献